A female patient who has been off phentermine for one year after previously taking 37.5 mg, what starting dose of phentermine should be prescribed?

Restart at 15 mg Phentermine

For a patient who has been off phentermine for one year after previously taking 37.5 mg, restart at 15 mg once daily in the morning, then titrate to 37.5 mg based on response and tolerability after 2-4 weeks.

Dosing Algorithm

The FDA-approved dosing strategy emphasizes individualization to achieve adequate response with the lowest effective dose 1. After a one-year medication-free interval, the patient should be treated as if initiating therapy:

Initial dosing approach:

• Start at 15 mg once daily taken approximately 2 hours after breakfast
• Assess response and tolerability at 2-4 weeks
• If weight loss is inadequate (<3% body weight) and medication is well-tolerated, increase to 30-37.5 mg once daily
• Alternative: Some patients respond adequately to even lower doses (9.375 mg or 18.75 mg) 2

Rationale for Lower Starting Dose

Multiple guidelines support starting at the lower end of the dosing range 2, 3, 4. The 2022 AGA Clinical Practice Guideline explicitly states that phentermine is available in 15 mg, 30 mg, and 37.5 mg formulations, with the recommended dosage being "once daily up to 37.5 mg" 4. The 2017 Gastroenterology guidelines note that "the recommended dosage of phentermine is 15 to 37.5 mg orally once daily" and emphasize that "dosage should be individualized to achieve adequate response with the lowest effective dose" 3.

Key consideration: After a one-year hiatus, the patient has no residual drug effect or tolerance. Starting at 15 mg allows assessment of:

• Current medication sensitivity
• Cardiovascular response (heart rate and blood pressure changes)
• Side effect profile (insomnia, dry mouth, anxiety, irritability)
• Appetite suppression efficacy

Evidence for Dose Flexibility

Research demonstrates that 15 mg phentermine produces clinically meaningful weight loss. A 28-week RCT showed that phentermine 15 mg daily resulted in 6.0 kg weight loss, with 46% achieving ≥5% weight loss and 20.8% achieving ≥10% weight loss 3. A Mexican study comparing 15 mg versus 30 mg found that while 30 mg was more effective at 3 months, by 6 months there was no significant difference between doses 5.

Titration Strategy

If starting at 15 mg:

• Week 0-2: 15 mg once daily in the morning
• Week 2-4: Assess weight loss, side effects, vital signs
• Week 4+: If <3% weight loss and well-tolerated, increase to 30-37.5 mg once daily

The FDA label confirms that "dosage should be individualized to obtain an adequate response with the lowest effective dose" with usual adult doses ranging from 15-30 mg 1.

Critical Safety Monitoring

Before restarting and during titration, monitor:

• Blood pressure and heart rate at each visit (phentermine causes mild sympathetic stimulation) 3, 4
• Cardiovascular history: Contraindicated in uncontrolled hypertension, coronary artery disease, arrhythmias 1
• Psychiatric symptoms: Avoid in patients with anxiety disorders; monitor for worsening insomnia, irritability 3, 4
• Thyroid function: Contraindicated in hyperthyroidism 1

Common Pitfalls to Avoid

1. Don't automatically restart at 37.5 mg just because the patient previously tolerated this dose—cardiovascular risk factors may have changed during the year off medication
2. Don't prescribe late in the day—take in the morning to minimize insomnia 1
3. Don't combine with MAOIs or use within 14 days of MAOI discontinuation 1
4. Don't ignore the "short-term" FDA approval—phentermine is approved for only 12 weeks, though many clinicians use it longer off-label 4. Document rationale if continuing beyond 3 months

Duration Considerations

While FDA-approved for short-term use (<12 weeks), the 2022 AGA guideline acknowledges that "many experienced clinicians use phentermine for longer than 3 months in off-label fashion" 4. If long-term use is planned, document specific benefits, tolerance, adverse effects, and counsel the patient regarding off-label use 4. The ongoing LEAP trial (NCT05176626) is evaluating 24-month phentermine safety and efficacy 6.

Alternative Low-Dose Option

The 8 mg tablet formulation (Lomaira) can be dosed up to 3 times daily (24 mg total), allowing even more granular titration starting as low as 4 mg with the scored tablets 4. This may be appropriate for patients particularly sensitive to stimulant effects.